D. Cong et al., Absorption of benzoic acid in segmental regions of the vascularly perfusedrat small intestine preparation, DRUG META D, 29(12), 2001, pp. 1539-1547
Oral bioavailability is a consequence of intestinal absorption, exsorption,
and metabolism and is further modulated by the difference in activities am
ong segmental regions. The influence of these factors on the net absorption
of benzoic acid (BA), a substrate that is metabolized to hippurate and is
transported by the monocarboxylic acid transporter 1, was studied in the re
circulating, vascularly perfused, rat small intestine preparation. Metaboli
sm of BA was not observed for both systemic and intraluminal injections int
o segments of varying lengths. But, secretion of BA into lumen was noted. A
bsorption of BA (0.166-3.68 mu mol) introduced at the duodenal end for abso
rption by the entire intestine was complete (>95% dose at 2 h) and dose-ind
ependent, yielding similar absorption rate constants (k(a) of 0.0464 min(-1
)). The extent of absorption remained high (92-96% dose) when BA was inject
ed into closed segments of shorter lengths (12 or 20 cm), suggesting a larg
e reserve length of the rat intestine. However, k(a) was higher for the jej
unum (0.0519 and 0.0564 min(-1), respectively, for the 12- and 20-cm segmen
ts) and exceeded that for the duodenum (12-cm segment, 0.0442 min(-1)) and
ileum (20-cm segment, 0.0380 min(-1)) at closed injection sites. The findin
g paralleled the distribution of monocarboxylic acid transporter isoform 1
detected by Western blotting along the length of the small intestine. Fits
of the systemic and oral data (based on duodenal injection for absorption b
y the whole intestine) to the traditional, physiological model and to the s
egregated flow model (SFM) that describes partial intestinal flow to the en
terocyte region showed a better fit with the SFM even though metabolite dat
a were absent.